First off, a quick note that the Super Income Portfolio is doing everything we expected, and the consistent dividends keep rolling in.

Next, I’ve got a new speculative gene-editing pick that’s just starting to hit its stride – we want to be positioned on this one before the other analysts notice.

There are potential catalysts coming down the pike that could push shares up 50% in a day.

Let’s not waste any more time – let’s get into it!